Clarification sought from Sequent Scientific

27 Jul 2015 Evaluate

Sequent Scientific has informed that they referred to the news item in Economic Times on July 27, 2015 titled Sequent Unit set to buy Mumbai based Lykas veterinary business. Sequent has a stated strategic intent of creating a global powerhouse in animal health business through its subsidiary Alivira Animal Health Ltd. Towards this objective, the Company continues to explore and evaluate strategic growth opportunities, including inorganic opportunities. Whenever, there is any event or information that will have a significant bearing on the performance of the Company or any price-sensitive event, they will promptly inform the stock exchanges. Company has nothing specific to report at this point of time.

The above information is a part of company’s filings submitted to BSE.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×